SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
INTERCEPT PHARMACEUTICALS INC
(NQNM:ICPT Last Sale: 78.64 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ICPT : $78.64)
$2,583,565 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Research Report Earnings Snapshot - Last 11/06/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


Focus is novel therapeutics to treat chronic liver disease utilizing expertise in bile acid chemistry. IPO at $15 October 10, 2012. Raised $75 million, selling 5 million shares, 32% of the outstanding. Lead Manager: Banc of America.
Historical Charts    Technical Analysis
No Historical Data available for ICPT

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ICPT $78.64 $78.64 0 .0 $75.37 $78.74 756,486 $75.37 $78.74 32,853,066
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock #############

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex